TG THERAPEUTICS, INC. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Tg Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q3 2024.
  • Tg Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $7.41M, a 10.4% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $7.41M -$860K -10.4% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $7.66M -$812K -9.58% Jun 30, 2024 10-Q 2024-08-09
Q1 2024 $7.91M -$783K -9.01% Mar 31, 2024 10-Q 2024-05-06
Q4 2023 $8.05M -$838K -9.43% Dec 31, 2023 10-Q 2024-11-07
Q3 2023 $8.27M -$808K -8.9% Sep 30, 2023 10-Q 2023-11-06
Q2 2023 $8.48M -$308K -3.51% Jun 30, 2023 10-Q 2023-08-04
Q1 2023 $8.69M -$275K -3.07% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 $8.89M +$259K +3% Dec 31, 2022 10-K 2024-02-29
Q3 2022 $9.08M +$275K +3.12% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $8.78M -$190K -2.12% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $8.96M -$177K -1.94% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $8.63M -$683K -7.34% Dec 31, 2021 10-K 2023-03-01
Q3 2021 $8.8M -$179K -1.99% Sep 30, 2021 10-Q 2021-11-08
Q2 2021 $8.97M -$168K -1.84% Jun 30, 2021 10-Q 2021-08-06
Q1 2021 $9.14M -$153K -1.65% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 $9.31M -$90K -0.96% Dec 31, 2020 10-K 2022-03-01
Q3 2020 $8.98M +$490K +5.77% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 $9.14M +$1.48M +19.4% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $9.29M +$1.35M +17% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 $9.4M +$9.4M Dec 31, 2019 10-K 2021-03-01
Q3 2019 $8.49M Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $7.66M Jun 30, 2019 10-Q 2019-08-09
Q1 2019 $7.95M Mar 31, 2019 10-Q 2019-05-10
Q4 2018 $0 Dec 31, 2018 10-K 2020-03-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.